Search results

• Efavirenz
  ...resolution and the mechanism of resistance to non-nucleoside inhibitors | journal=Proc Natl Acad Sci USA | volume=99 | pages=14410–15 | pmid=12386343 | doi ...rend in emerging nations - Brazil opts for Indian generic drug ignoring US pharmaceutical giant Merck’s patent on AIDS drug Efavirenz<!-- Bot generated title -->]<
  10 KB (1,441 words) - 16:45, 27 September 2010
• Lopinavir
  ...ntration for HIV | author=Capparelli E, Holland D, Okamoto C, ''et al.'' | journal=AIDS (London, England) | year=2005 | volume=19 | issue=9 }}</ref> ...y.pdf AIDES "People Living with HIV: Let's change the rules imposed by the pharmaceutical industry!" (July 1st, 2007)]</ref>
  8 KB (1,109 words) - 16:45, 27 September 2010
• Ritonavir
  ...ow generic production of Norvir, citing potential adverse effects on the [[pharmaceutical]] market.<ref>{{cite web| url=http://www.washingtonpost.com/wp-dyn/articles ...avir-boosted protease inhibitor therapy in HIV-infected patients |journal= Journal of Antimicrobial Chemotherapy|volume=53|pages=4–9|year=2004 |doi=10.1093
  9 KB (1,233 words) - 15:07, 6 July 2010
• Nelfinavir
  ...ns: structural identification, levels in plasma, and antiviral activities |journal=Antimicrob. Agents Chemother. |volume=45 |issue=4 |pages=1086–93 |year=20 ...t launched proved to be the largest "biotech launch" in the history of the pharmaceutical industry achieving first full year sales exceeding $335M US.
  8 KB (1,160 words) - 16:45, 27 September 2010
• Ribavirin
  | legal_status = Ethical U.S. pharmaceutical; Not DEA-controlled. ...ibavirin for chronic hepatitis C virus infection in HIV-infected patients |journal=N. Engl. J. Med. |volume=351 |issue=5 |pages=438–50 |year=2004 |month=Jul
  23 KB (3,222 words) - 16:45, 27 September 2010
• Codeine
  ...apabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17 |journal=Drug Metab. Dispos. |volume=35 |issue=8 |pages=1292–300 |year=2007 |month ...tle=Codeine analgesia is due to codeine-6-glucuronide (C6G), not morphine |journal=Int. J. Clin. Pract. |volume=54 |issue=6 |pages=395&ndash;8 |year=2000 |pmi
  40 KB (5,581 words) - 16:45, 27 September 2010
• 4-Aminosalicylic acid
  ...tuberculosis Role of individual drugs in the chemotherapy of tuberculosis|journal=Int J Tuberc Lung Dis|volume=4|issue=9|pages=796–806|pmid=10985648|year=2 ...: A report of four cases|author=Smith NP, Ryan TJ, Sanderson KV, Sarkany I|journal=Br J Dermatol|volume=94|issue=3|pages=319–325|doi=10.1111/j.1365-2133.197
  7 KB (879 words) - 16:46, 27 September 2010
• Ketamine
  ...CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes |journal=Drug Metabolism and Disposition |volume=30 |issue=7 |pages=853–8 |year=20 ...=Ketamine: review of its pharmacology and its use in pediatric anesthesia |journal=Anesthesia Progress |volume=46 |issue=1 |pages=10–20 |year=1999 |pmid=105
  69 KB (9,697 words) - 21:01, 24 September 2010
• Ciprofloxacin
  ...eslie J, Caldwell J |title=Absolute oral bioavailability of ciprofloxacin |journal=Antimicrob Agents Chemother. |volume=30 |issue=3 |pages=444–6 |year=1986 ...= Kawahara | first1 = S. | title = [Chemotherapeutic agents under study] | journal = Nippon Rinsho | volume = 56 | issue = 12 | pages = 3096–9 | month = Dec
  88 KB (11,930 words) - 16:46, 27 September 2010
• Azithromycin
  ...[Mycoplasma pneumoniae pneumonia]] with azithromycin prophylaxis | journal=Journal of Infectious Diseases | year=1998 | volume=177 | pages=161–166 | doi=10. A team of researchers at the [[Croatia]]n pharmaceutical company [[Pliva]], Gabrijela Kobrehel, Gorjana Radobolja-Lazarevski and Zri
  15 KB (2,008 words) - 16:46, 27 September 2010
• Metformin
  ...iabetes Association]] |title=Standards of medical care in diabetes—2009 |journal=Diabetes Care |volume=32 Suppl 1 |pages=S13–61 |year=2009 |pmid=19118286 ...{{vcite journal |author=Witters L |title=The blooming of the French lilac |journal=J Clin Invest |volume=108 |issue=8 |pages=1105–7 |year=2001 |pmid=1160261
  66 KB (8,976 words) - 16:47, 27 September 2010
• Fluoxetine
  ...itor and an antidepressant drug: twenty years since its first publication |journal=Life Sci |volume=57 |issue=5 |pages=411–41 |year=1995 |pmid=7623609 |doi= ...: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine |journal=Life Sci |volume=15 |issue=3 |pages=471–9 |year=1974 |pmid=4549929 |doi=1
  52 KB (7,168 words) - 16:47, 27 September 2010
• Aspirin
  ...]] formation in people at high risk for developing blood clots.<ref>{{Cite journal| doi = 10.1056/NEJM198308183090703| issn = 00284793| volume = 309| issue = ...farction in Elderly Medicare Beneficiaries : Patterns of Use and Outcomes| journal = Circulation| year = 1995|pmid = 7586250}}</ref>
  78 KB (10,918 words) - 16:52, 27 September 2010
• Prussian blue
  ...rly use of prussian blue in paintings| format= PDF| author = Jens Bartoll| journal = 9th International Conference on NDT of Art, Jerusalem Israel, 25-30 May 2 ...s makes it useful as a sequestering agent for certain heavy metal poisons. Pharmaceutical-grade Prussian blue in particular is used for patients who have ingested [[
  20 KB (3,004 words) - 16:47, 27 September 2010
• Ampicillin
  ...61. Until the introduction of ampicillin by the British company [[Beecham (pharmaceutical company)|Beecham]], penicillin therapies had only been effective against [[ ...moss (Physcomitrella patens) but not in tomato (Lycopersicon esculentum). Journal of [[Plant Physiology]] 150, 137-140. [http://cat.inist.fr/?aModele=affiche
  7 KB (881 words) - 16:47, 27 September 2010
• Cloxacillin
  ...as [[penicillin]]. Cloxacillin was discovered and developed by [[Beecham (pharmaceutical company)|Beecham]]. It is sold under a number of trade names, including ''' ...oagulase negative staphylococcal bacteremia: a retrospective cohort study |journal=BMC Pediatr |volume=5 |issue= |pages=49 |year=2005 |pmid=16375769 |pmc=1343
  3 KB (349 words) - 11:25, 20 September 2010
• Co-amoxiclav
  ...name such as '''Augmentin''' (by [[GlaxoSmithKline]] formerly [[Beecham (pharmaceutical company)|Beecham]]),<ref name="BNF">{{cite book |title=[[British National F ...riginal name used by its inventor ([[GlaxoSmithKline]] formerly [[Beecham (pharmaceutical company)|Beecham]]).
  7 KB (895 words) - 16:48, 27 September 2010
• Amlodipine
  ...re of (''R'')-(+)- and (''S'')-(–)-amlodipine]<ref name=Luksa1997>{{cite journal |journal=Journal of Chromatography. B, Biomedical Sciences and Applications
  12 KB (1,641 words) - 15:32, 16 September 2010
• Digoxin
  ...in comes from Digitalis lanata | year = 1996 | journal = [[British Medical Journal]] | format = letter | volume = 312 | issue = 7035 | pages = 912 | url = htt ...in patients with and without cardiac autonomic innervation | year = 1975 | journal = [[Circulation]] | volume = 51 | issue = 2 | pages = 251–256 | url = htt
  19 KB (2,738 words) - 16:48, 27 September 2010
• Simvastatin
  ...associated with a reduced incidence of dementia and Parkinson's disease | journal =BMC Medicine | volume =5 | pages =20 | date =July 19, 2007 | doi =10.1186/ ...title =SLCO1B1 variants and statin-induced myopathy--a genomewide study. | journal =N Engl J Med. | volume =359(8) | pmid =18650507 | year = 2008 | first1 = G
  14 KB (1,967 words) - 16:48, 27 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)